Surface Oncology (SURF) Stock is Lower After Announcing Presentation of Preliminary Data at ...

Retrieved on: 2021-06-04 15:00:00

Tags for this article:

Click the tags to see associated articles and topics

Surface Oncology (SURF) Stock is Lower After Announcing Presentation of Preliminary Data at .... View article details on hiswai:

Excerpt

Shares of SURF declined 2.76% to $8.81. What does this mean for Surface Oncology? SRF388 is an antibody against IL-27, an immunosuppressive ...

Article found on: www.investorsobserver.com